Vedanta Biosciences' Grant - II Round

Vedanta Biosciences raised a round of funding on July 10, 2018. Investors include Crohn's & Colitis Foundation of America.

Vedanta Biosciences has built a proprietary platform for the discovery, development, and manufacturing of drugs based on live commensal microbes. Using Vedanta's platform, the company has isolated a v…

Articles about Vedanta Biosciences' Grant - II Round: